Cancer-Critical Genes I: Proto-oncogenes

Proto-oncogenes are normal genes that encode proteins controlling cell division and growth signaling. Under normal conditions, these genes regulate cellular growth through signal-transduction pathways that respond to activation signals. When functioning properly, proto-oncogenes maintain controlled cell proliferation necessary for healthy tissue development and maintenance.

Gain-of-function mutations alter proto-oncogenes to produce overactive proteins that continuously activate growth signaling pathways without requiring external activation signals. This constant activation leads to uncontrolled cell proliferation. These mutations are typically dominant, meaning even a single mutated copy can transform the proto-oncogene into a cancer-causing oncogene.

When the Ras proto-oncogene mutates, it produces a defective protein that permanently switches on cell growth signaling cascades. Unlike normal Ras, the mutated version remains active even without activation signals, causing cells to divide uncontrollably and eventually form tumors through continuous growth stimulation.

Proto-oncogenes cause cancer when they become overactive through gain-of-function mutations, while cancer-critical genes ii tumor suppressor genes cause cancer when they lose function or become inactivated. Proto-oncogenes drive excessive cell growth when mutated, whereas tumor suppressors normally restrain cell division and must be disabled for cancer to develop.

Gain-of-function mutations in proto-oncogenes are dominant because a single mutated copy produces enough overactive protein to drive uncontrolled cell growth. The mutated allele does not require a normal copy to function, so even heterozygous cells with one mutated proto-oncogene can develop into tumors without needing both copies to be affected.

Common human proto-oncogenes include Ras, HER2, Myc, and Cyclin D. These genes normally regulate essential cellular processes like growth signaling and cell cycle progression. When mutated, any of these proto-oncogenes can contribute to tumor formation by producing proteins that drive excessive cell proliferation.

Mutations in proto-oncogenes cause overexpression of cell-growth proteins, resulting in uncontrolled cell proliferation. Cells with activated oncogenes continuously receive growth signals regardless of normal regulatory mechanisms. This persistent proliferation allows abnormal cells to accumulate and eventually develop into tumors through continuous, unregulated division.